Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day

Go back to Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day
(NASDAQ: DFTX) Delayed: 36.18 -0.49 (1.34%)
Previous Close $36.67    52 Week High
Open $36.42    52 Week Low
Day High $39.13    P/E N/A 
Day Low $35.25    EPS
Volume 5,640,440